Hikma Pharmaceuticals is a British pharmaceutical company headquartered in London. Founded in 1978, it focuses on developing, manufacturing, marketing and selling a wide range of generic, non-branded, branded and in-licensed medical products in various forms, including liquid, semi-solid, and injectables. Hikma is a global business with 32 manufacturing plants and 7 research and development centres across Europe, the Middle East, the US, and North Africa. The company’s therapeutic areas of interest include cardiovascular, oncology, anti-infectives, respiratory, central nervous system, diabetes, and pain management, where it offers more than 780 products to patients. Hikma Pharmaceuticals stock is listed on the London Stock Exchange and is a constituent of the FTSE 100 index. Start spread betting or trading CFDs on our Hikma share price.